Effect of bisphosphonates on bone mineral density and fracture prevention in gastric cancer patients after gastrectomy

Journal of Clinical Gastroenterology

Volumn 46, Issue 8, 2012, Pages 669-674

  Lim, Jung Sub ^a   Jin, Sung Ho ^a   Kim, Sang Bum ^a   Lee, Jong Inn ^a  

^a Korea Cancer Central Hospital   (South Korea)

Author keywords

bisphosphonates; fracture; gastrectomy; gastric cancer; osteoporosis

Indexed keywords

ALENDRONIC ACID; CALCIUM; PAMIDRONIC ACID; RISEDRONIC ACID; VITAMIN D;

ADULT; ARTICLE; BONE DENSITY; BONE PAIN; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FOLLOW UP; FRACTURE; GASTRECTOMY; GASTROINTESTINAL DISEASE; HEARTBURN; HUMAN; HYPOCALCEMIA; LUMBAR SPINE; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; STOMACH CANCER; VERTEBRA FRACTURE;

ABSORPTIOMETRY, PHOTON; ADENOCARCINOMA; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; FEMUR NECK; FRACTURES, BONE; GASTRECTOMY; HUMANS; LUMBAR VERTEBRAE; MALE; OSTEOPOROSIS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84865470139     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31824f1af4     Document Type: Article

References (31)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. Cancer J Clin. 2005;55:74-108.
2. Lee HJ, Yang HK, Ahn YO. Gastric cancer in Korea. Gastric Cancer. 2002;5:177-182.
3. Liedman B. Symptoms after total gastrectomy on food intake, body composition, bone metabolism, and quality of life in gastric cancer patients-is reconstruction with a reservoir worthwhile? Nutrition. 1999;15:677-682.
4. Tovey FI, Hall ML, Ell PJ, et al. A review of postgastrectomy bone disease. Gastroenterol Hepatol. 1992;7:639-645.
5. Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology. 2003;124:795-841.
6. Lim JS, Kim SB, Bang HY, et al. High prevalence of osteoporosis in patients with gastric adenocarcinoma following gastrectomy. World J Gastroenterol. 2007;13:6492-6497.
7. Rodan GA, Fleisch HA. Bisphosphonates: Mechanisms of action. J Clin Invest. 1996;97:2692-2696.
8. Drake MT, Clarke BL, Khosla S. Bisphosphonates: Mechanism of action and role in clinical practice. Mayo Clin Proc. 2008;83:1032-1045.
9. Pols HA, Felsenberg D, Hanley DA, et al. Multinational, placebocontrolled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: Results of the FOSIT study. Fosamax International Trial Study Group. Osteoporos Int. 1999;9:461-468.
10. Ho YV, Frauman AG, Thomson W, et al. Effects of alendronate on bone density in men with primary and secondary osteoporosis. Osteoporos Int. 2000;11:98-101.
11. Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999;282:1344-1352.
12. Lin JH, Chen IW, de Luna FA. On the absorption of alendronate in rats. J Pharm Sci. 1994;83:1741-1746.
13. Drake MT, Clarke BL, Khosla S. Bisphosphonates: Mechanism of action and role in clinical practice. Mayo Clin Proc. 2008;83:1032-1045.
14. Iwamoto J, Uzawa M, Sato Y, et al. Effect of alendronate on bone mineral density and bone turnover markers in postgastrectomy osteoporotic patients. J Bone Miner Metab. 2010;28:202-208.
15. Suzuki Y, Ishibashi Y, Omura N, et al. Alendronate improves vitamin D-resistant osteopenia triggered by gastrectomy in patients with gastric cancer followed long term. J Gastrointest Surg. 2005;9:955-960.
16. Lim JS, Hwang JS, Lee JA, et al. Bone mineral density according to age, bone age, and pubertal stages in Korean children and adolescents. J Clin Densitom. 2010;13:68-76.
17. Iba K, Wada T, Takada J, et al. Multiple insufficiency fractures with severe osteoporosis. J Orthop Sci. 2003;8:717-720.
18. Zittel TT, Zeeb B, Maier GW, et al. High prevalence of bone disorders after gastrectomy. Am J Surg. 1997;174:431-438.
19. Melton LJ III, Crowson CS, Khosla S, et al. Fracture risk after surgery for peptic ulcer disease: A population-based cohort study. Bone. 1999;25:61-67.
20. Mellström D, Rundgren A. Long-term effects after partial gastrectomy in elderly men. A longitudinal population study of men between 70 and 75 years of age. Scand J Gastroenterol. 1982;17:433-439.
21. Iwamoto J, Takeda T, Sato Y. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis. Curr Med Res Opin. 2006;22:919-928.
22. Liberman UA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl JMed. 1995;333:1437-1443.
23. Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348:1535-1541.
24. Gass M, Dawson-Hughes B. Preventing osteoporosis-related fractures: An overview. Am J Med. 2006;119(4 Suppl 1):S3-S11.
25. Abrahamsen B. Adverse effects of bisphosphonates. Calcif Tissue Int. 2010;86:421-435.
26. Emkey R. Alendronate and risedronate for the treatment of postmenopausal osteoporosis: Clinical profiles of the onceweekly and once-daily dosing formulations. Med Gen Med. 2004;6:6.
27. Brown JP, Kendler DL, McClung MR, et al. The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis. Calcif Tissue Int. 2002;71:103-111.
28. Søvik TT, Aasheim ET, Taha O, et al. Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: A randomized trial. Ann Intern Med. 2011;155:281-291.
29. Eddy RL. Metabolic bone disease after gastrectomy. Am J Med. 1971;50:442-449.
30. Bisballe S, Eriksen EF, Melsen F, et al. Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodeling, vitamin D metabolites, and bone histomorphometry. Gut. 1991;32:130-137.
31. Alhava EM, Aukee S, Karjalainen P, et al. The influence of calcium and calcium+vitamin D2 treatment on bone mineral after partial gastrectomy. Scand J Gastroenterol. 1975;10:689-693.